These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6385872)

  • 1. Interleukin-2 production in bullous pemphigoid.
    Ahmed AR; Hijri K; Arab-Kermani V
    Arch Dermatol Res; 1984; 276(5):330-2. PubMed ID: 6385872
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the autoimmune pathogenesis of bullous pemphigoid. Review of the literature and our results (author's transl)].
    Haustein UF; Lohrisch I; Herrmann K
    Dermatol Monatsschr; 1980 Sep; 166(9):585-98. PubMed ID: 7004925
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte studies in bullous pemphigoid.
    Ahmed AR
    J Dermatol; 1981 Oct; 8(5):385-9. PubMed ID: 7035512
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2 receptor expression and interleukin-2 production in bullous pemphigoid.
    Schaller J; Giese T; Ladusch M; Haustein UF
    Arch Dermatol Res; 1990; 282(4):223-6. PubMed ID: 1973607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progresses and perspectives in autoimmune bullous diseases.
    Sadik CD; Schmidt E; Zillikens D; Hashimoto T
    J Allergy Clin Immunol; 2020 Apr; 145(4):1145-1147. PubMed ID: 32272983
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
    Stanley JR
    J Clin Invest; 1989 May; 83(5):1443-8. PubMed ID: 2651476
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlation between immunologic reactivity and the clinical development in a case of bullous pemphigoid].
    Renoux M; Paulay AM; Carli-Basset C; Lorette G; Renoux G
    Ann Dermatol Venereol; 1980; 107(11):1095-6. PubMed ID: 7015971
    [No Abstract]   [Full Text] [Related]  

  • 8. [Impairment of sheep erythrocyte rosette formation by sera from patients with bullous pemphigoid].
    Schaller J; Haustein UF; Lohrisch I
    Dermatol Monatsschr; 1986; 172(9):535-40. PubMed ID: 3539651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pseudo-T cell defect in bullous pemphigoid].
    Schaller J; Haustein UF; Lohrisch I
    Dermatol Monatsschr; 1986; 172(6):318-24. PubMed ID: 3527800
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 11. An immunological study of patients with bullous pemphigoid.
    Hovmark A; Asbrink E
    Acta Derm Venereol; 1982; 62(3):201-4. PubMed ID: 6179358
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immune reaction in the mechanism of blister formation in bullous pemphigoid.
    Takiguchi Y; Kamiyama O; Saito E; Nagao S; Kaneko F; Minagawa T
    Dermatologica; 1989; 179 Suppl 1():137. PubMed ID: 2673853
    [No Abstract]   [Full Text] [Related]  

  • 13. Pemphigoid gestationis: a unique mechanism of initiation of an autoimmune response by MHC class II molecules?
    Kelly SE; Black MM; Fleming S
    J Pathol; 1989 May; 158(1):81-2. PubMed ID: 2666624
    [No Abstract]   [Full Text] [Related]  

  • 14. Animal models for bullous pemphigoid.
    Anhalt GJ; Diaz LA
    Clin Dermatol; 1987; 5(1):117-25. PubMed ID: 3552181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
    Muramatsu T; Sakamoto K; Ikeda S
    Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity in bullous diseases.
    Ahmed AR
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):481-4. PubMed ID: 7042775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathological aspects of autoimmune bullous dermatoses].
    Grando SA; Glukhen'kiĭ BT; Kutsenko NS; Kostromin AP; Demidov SV
    Vrach Delo; 1987 Sep; (9):94-7. PubMed ID: 3321707
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
    Patel HP; Anhalt GJ; Provost TT; Diaz LA
    Clin Immunol Rev; 1983-1984; 2(2):157-86. PubMed ID: 6370527
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-10-producing B-cells in autoimmune bullous diseases.
    Hashimoto T; Mizoguchi A
    Br J Dermatol; 2017 May; 176(5):1119-1120. PubMed ID: 28504377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.